Article
Targeting Hypercalciuria in SLC34A1-Related Disorders: Impact of Oral Phosphate Therapy and Novel Genetic Insights in Pediatric Case Series.
Calcified tissue international - 16 Jan 2026
Turan Ihsan, Atar Muge, Eltan Mehmet, Anik Ahmet, Bitkin Eda Celebi, Dilek Semine Ozdemir, Cay Mevra, Bozdogan Sevcan Tuğ, Döneray Hakan, Kotan Damla, Turan Serap, Yüksel Bilgin, Topaloglu Ali Kemal
Abstract excerpt
Pathogenic variants in the SLC34A1 gene, which encodes the sodium-phosphate cotransporter NaPi-IIa, lead to a spectrum of renal tubular disorders, including infantile hypercalcemia type 2, nephrolithiasis/osteoporosis-hypophosphatemia type 2, and Fanconi renotubular syndrome type 2. Despite increasing recognition of SLC34A1-related disorders, data on genotype-phenotype correlations and treatment response remain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
